⌘K
t
On 1 June 2022, Johnson Matthey Plc completed the sale of its Health business to Altaris Capital Partners for a total consideration of £325 million. Johnson Matthey will retain approximately a 30% equity stake in the Health business, which has been rebranded as Veranova.
| Date | 1 Jun 2022 |
| Time | 07:00:07 |
| Category | Disposals |
| ID | 4645N |
Johnson Matthey Plc (JM), a global leader in sustainable technologies, today announces that that it has completed the sale of its Health business in accordance with the terms of the sale agreement entered into between JM and Altaris Capital Partners ("Altaris"), a leading healthcare investment firm.
The Health business, which has been rebranded as Veranova, was sold for a total consideration of £325 million. As part of the transaction, JM will retain approximately a 30% equity stake in Veranova.
ENDS
Johnson Matthey is a global leader in sustainable technologies that enable a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, energy, chemical processing and making the most efficient use of the planet's natural resources. Today about 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com
Inspiring science, enhancing life
Media
0207 269 8001
Investor Relations
Martin Dunwoodie Director of Investor Relations 0207 269 8241
Louise Curran Senior Investor Relations Manager 0207 269 8235
Carla Fabiano Senior Investor Relations Manager 0207 269 8004